TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive Natcher: Multiple Year Funding Would Not be Approved If Presented As Request For Reprogramming March 22, 1985
TCL Archive USPSTF and ACS Recommend Less Frequent Cervical Cancer Screenings and Pap Smears March 30, 2012
